Chest pain—a strong predictor of adverse cardiac events following percutaneous intervention (from the Evaluation of Platelet IIb/IIIa Inhibitor for Stenting Trial [EPISTENT])

✍ Scribed by Mark A. Robbins; Steven P. Marso; Kathy Wolski; John Peterson; A.Michael Lincoff; Sorin Brener

• Book ID: 113980963
• Publisher: Elsevier Science
• Year: 1999
• Tongue: English
• Weight: 119 KB
• Volume: 84
• Category: Article
• ISSN: 0002-9149
• DOI: 10.1016/s0002-9149(99)00572-x